| Mepha Pharma AG - Quetiapin-Mepha retard 150 mg, Retardtabletten | | 62649 | | 05 | | Quetiapin-Mepha retard 150 mg | | Retardtabletten | | N05AH04 | | Quetiapine | | 08.12.2017 | | |
| | Composition | | quetiapinum 150 mg ut quetiapini fumaras, hypromellosum, cellulosum microcristallinum, natrii citras anhydricus, magnesii stearas, Überzug: hypromellosum, macrogolum 400, polysorbatum 80, E 171, pro compresso obducto corresp., natrium 16.978 mg. | | Packungsbestandteile | | Delayed release tablets | | | | | Active Agent | Dose |
|---|
| Quetiapine | 150 mg |
| | BAG: Active Agent | Dose |
|---|
| Quetiapine | 150 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Cellulosum Microcristallinum | | | | E 171 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Natrii Citras Anhydricus | | | | Polysorbatum 80 | | | | Pro Compresso Obducto | | |
| |
| |
|
